On June 4, 2012, CromSource, an international contract research organization (CRO), acquired Pleiad Devices, an established CRO with offices in the United States (Cambridge, Massachusetts) and the United Kingdom (Stirling, Scotland).

By combining their resources and expertise, CromSource and Pleiad aim to deliver an enhanced level of service to their clients, accelerate the development of new therapies, and improve patient outcomes. The acquisition strengthens CromSource's position as a global leader in the CRO industry and underscores its commitment to providing high-quality clinical research services.